Stem Cells in Acute Liver Failure

Advances in Surgery

Volumn 45, Issue 1, 2011, Pages 117-130

  Wesson, Russell N ^a   Cameron, Andrew M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HETEROCYCLIC COMPOUND; PLERIXAFOR; SCATTER FACTOR;

ACUTE LIVER FAILURE; ANIMAL; DRUG ANTAGONISM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER REGENERATION; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOCYTE GROWTH FACTOR; HETEROCYCLIC COMPOUNDS; HUMANS; LIVER FAILURE, ACUTE; LIVER REGENERATION; RECEPTORS, CXCR4; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 79961206206     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2011.03.001     Document Type: Review

References (54)

1. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
2. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170.
3. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6:1229-1234.
4. Theise N.D., Badve S., Saxena R., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31:235-240.
5. Theise N.D., Nimmakayalu M., Gardner R., et al. Liver from bone marrow in humans. Hepatology 2000, 32:11-16.
6. Leone A.M., Rutella S., Bonanno G., et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 2006, 111:202-208.
7. Achilli F., Malafronte C., Lenatti L., et al. Granulocyte colony-stimulating factor attenuates left ventricular remodeling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial. Eur J Heart Fail 2010, 12:1111-1121.
8. Stokman G., Leemans J.C., Claessen N., et al. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J Am Soc Nephrol 2005, 16:1684-1692.
9. Farmer D.G., Anselmo D.M., Ghobrial R.M., et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003, 237:666-675. [discussion: 675-6].
10. Dhiman R.K., Seth A.K., Jain S., et al. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998, 43:1311-1316.
11. Gazzard B.G., Portmann B., Murray-Lyon I.M., et al. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975, 44:615-626.
12. Bernal W., Wendon J., Rela M., et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998, 27:1050-1055.
13. Lee W.M. Acute liver failure. N Engl J Med 1993, 329:1862-1872.
14. O'Grady J.G., Alexander G.J., Hayllar K.M., et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97:439-445.
15. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science 1997, 276:60-66.
16. Rabes H.M., Wirsching R., Tuczek H.V., et al. Analysis of cell cycle compartments of hepatocytes after partial hepatectomy. Cell Tissue Kinet 1976, 9:517-532.
17. Martinez-Hernandez A., Amenta P.S. The extracellular matrix in hepatic regeneration. FASEB J 1995, 9:1401-1410.
18. Overturf K., Al-Dhalimy M., Tanguay R., et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996, 12:266-273.
19. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001, 33:738-750.
20. Kuwahara R., Kofman A.V., Landis C.S., et al. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology 2008, 47:1994-2002.
21. Paku S., Schnur J., Nagy P., et al. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol 2001, 158:1313-1323.
22. Terrace J.D., Hay D.C., Samuel K., et al. Side population cells in developing human liver are primarily haematopoietic progenitor cells. Exp Cell Res 2009, 315:2141-2153.
23. Sirica A.E. Ductular hepatocytes. Histol Histopathol 1995, 10:433-456.
24. Novikoff P.M., Ikeda T., Hixson D.C., et al. Characterizations of and interactions between bile ductule cells and hepatocytes in early stages of rat hepatocarcinogenesis induced by ethionine. Am J Pathol 1991, 139:1351-1368.
25. Vassilopoulos G., Wang P.R., Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422:901-904.
26. Parekkadan B., van Poll D., Megeed Z., et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007, 363:247-252.
27. Stutchfield B.M., Forbes S.J., Wigmore S.J. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl 2010, 16:827-836.
28. Quesenberry P.J., Dooner G., Colvin G., et al. Stem cell biology and the plasticity polemic. Exp Hematol 2005, 33:389-394.
29. Simmons D.L., Satterthwaite A.B., Tenen D.G., et al. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 1992, 148:267-271.
30. De Silvestro G., Vicarioto M., Donadel C., et al. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 2004, 51:805-810.
31. Di Campli C., Piscaglia A.C., Giuliante F., et al. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc 2005, 37:2563-2566.
32. Gehling U.M., Willems M., Dandri M., et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005, 43:845-853.
33. Lemoli R.M., Catani L., Talarico S., et al. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 2006, 24:2817-2825.
34. Uy G.L., Rettig M.P., Cashen A.F. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther 2008, 8:1797-1804.
35. Hahn T., Wolff S.N., Czuczman M., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review. Biol Blood Marrow Transplant 2001, 7:308-331.
36. Flomenberg N., Devine S.M., Dipersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005, 106:1867-1874.
37. Liles W.C., Broxmeyer H.E., Rodger E., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003, 102:2728-2730.
38. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
39. Larochelle A., Krouse A., Metzger M., et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 2006, 107:3772-3778.
40. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002, 30:973-981.
41. Dar A., Kollet O., Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006, 34:967-975.
42. Terada R., Yamamoto K., Hakoda T., et al. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 2003, 83:665-672.
43. Dalakas E., Newsome P.N., Harrison D.J., et al. Hematopoietic stem cell trafficking in liver injury. FASEB J 2005, 19:1225-1231.
44. Kollet O., Shivtiel S., Chen Y.Q., et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003, 112:160-169.
45. Okumoto K., Saito T., Onodera M., et al. Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis. J Gastroenterol Hepatol 2007, 22:1265-1270.
46. Lorenzini S., Isidori A., Catani L., et al. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther 2008, 27:932-939.
47. Di Campli C., Zocco M.A., Saulnier N., et al. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis 2007, 39:1071-1076.
48. Gaia S., Smedile A., Omede P., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006, 45:13-19.
49. Yannaki E., Athanasiou E., Xagorari A., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005, 33:108-119.
50. Liu F., Liu Z.D., Wu N., et al. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl 2009, 15:1092-1100.
51. Sun Z., Zhang X., Locke J.E., et al. Recruitment of host progenitor cells in rat liver transplants. Hepatology 2009, 49:587-597.
52. Locke J.E., Sun Z., Warren D.S., et al. Generation of humanized animal livers using embryoid body-derived stem cell transplant. Ann Surg 2008, 248:487-493.
53. Mark A.L., Sun Z., Warren D.S., et al. Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg 2010, 252:591-596.
54. Ince H., Petzsch M., Kleine H.D., et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005, 112:I73-I80.